click below
click below
Normal Size Small Size show me how
Phar - AntiVir
Antiviral drugs
| Question | Answer |
|---|---|
| Acyclovir properties | HSV (weak varicella, CMV) drug, blocks viral DNA Pol. |
| Acyclovir pharmacokinetics | Oral, kidney, CSF |
| Ganciclovir properties | CMV drug (weaker HSV drug), blocks DNA Pol.(bone marrow toxicity |
| Ganciclovir pharmacokinetics | Poor oral, kidney, CSF |
| Foscarnet properties | Salvage drug when acyclovir & ganciclovir don't work. Pyrophosphate analog & competitive inhibitor of viral RNA, DNA Pol. and reverse transcriptase (nephrotoxic) |
| Foscarnet pharmacokinetics | Parenteral, kidney, CSF |
| Interferon properties | Hep C drug, regulates Jak/Stat pathway (bone marrow depression, flu-like symptoms - nasty drug, many quit) |
| Interferon pharmacokinetics | Parenteral |
| Telapravir | New Hep C drug, inhibits protease |
| Oseltamavir (Tamiflu)properties | Flu drug, neuraminidase inhibitor |
| Oseltamavir (Tamiflu) pharmacokinetics | Oral, liver, poor CSF |
| Zidovudine (AZT)properties | HIV drug, reverse transcriptase inhibitor (bone marrow depression) |
| Zidovudine (AZT) pharmacokinetics | Oral, liver/kidney, CSF |
| Lamivudine properties | HIV drug, reverse transcriptase inhibitor (selects mutation that is sensitive to AZT) |
| Lamivudine pharmacokinetics | Oral, kidney, CSF |
| Efavirenz properties | HIV drug, NNRTI (CNS toxicity, skin rashes) |
| Efavirenz pharmacokinetics | Oral, liver, CSF |
| Ritonavir properties | HIV drug, protease inhibitor, inhibits Cyp3A4 |
| Ritonavir pharmacokinetics | Oral, liver, CSF |
| Amprenavir (fosamprenovir) properties | HIV drug, protease inhibitor (lipodystrophy) |
| Amprenavir (fosamprenovir) pharmacokinetics | Oral, liver, CSF |
| Enfuvirtide properties | HIV drug, entry inhibitor |
| Enfuvirtide pharmacokinetics | Parenteral, NOT CSF |
| Raltegravir properties | HIV drug, inhibits HIV integrase |
| Raltegravir pharmacokinetics | Oral |